Results 171 to 180 of about 88,525 (289)

Arthroscopic Dissection and Protection of an Aberrant Suprascapular Nerve During Massive Rotator Cuff Repair

Arthroscopy Techniques, EarlyView.
Abstract The video demonstrates an arthroscopic technique for identification, dissection, and protection of the suprascapular nerve (SSN) during massive rotator cuff repair. The SSN, closely related to the transverse scapular ligament (TSL), may present anatomical variations that heighten the risk of iatrogenic injury.
Prince Shanavas Khan, Jimmy Joseph Meleppuram, Ayyappan V. Nair, Hamdi Nizar Ahamed, Nizaj Nasimudeen, Ananthakrishnan Radhakrishnan, Sanil Sathyadasan   +6 more
wiley   +1 more source

Bidirectional Roles of TRPV1 in a Latent Sensitization Model of Myofascial Low Back Pain. [PDF]

Eur J Pain
Blechschmidt V, Schlickenrieder B, Husk JR, Hoheisel U, Mörz H, Treede RD, Greffrath W.   +6 more
europepmc   +1 more source

Arthroscopic Segmental Labral Reconstruction Using a Presutured Iliotibial Band Allograft Soaked in Bone Marrow Aspirate Concentrate

Arthroscopy Techniques, EarlyView.
Abstract Labral reconstruction is a surgical procedure in which a graft is used to replace irreparable acetabular labral tissue. Biologic augmentation with bone marrow aspirate concentrate harvested from the ipsilateral iliac crest is increasingly used to enhance graft incorporation and potentially improve functional outcomes, especially in patients ...
Jacob D. Kodra, Arthur Saroyan, Kevin Lord, Andrew Schab, Jeremy K. Ansah‐Twum, Jon Salandra, Renato Locks, Andrew E. Jimenez   +7 more
wiley   +1 more source

Comparing Medicare Claims in Patients with Lumbar Discogenic Pain Managed Conservatively or with Intradiscal Nucleus Pulposus Allograft. [PDF]

J Pain Res
Girardi GE, Wilson DK, Patel RG, Yazdani S.   +3 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Abrupt Loss of Spinal Cord Stimulation After Trauma: A Case-Based Approach to Evaluation and Management. [PDF]

Orthop Rev (Pavia)
Hasoon J, Aner MM, Yazdi C, Robinson CL.
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Comparative Outcomes of Lumbar Platelet-Rich Plasma Injection Versus Conservative Treatment for Chronic Discogenic and/or Radicular Pain: A Retrospective Cohort Study. [PDF]

Biomedicines
Lee WY, Lee HY, Ko SH, Chiu PF, Li MY, Huang YL, Chen CL.   +6 more
europepmc   +1 more source

Effect of oxycodone vs. morphine as first‐line opioid on new persistent opioid use after orthopaedic surgery: A prospective sequential cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background Postoperative opioids, intended for short‐term analgesia, contribute to new persistent opioid use in 1%–7% of patients, adversely affecting outcomes. Oxycodone may carry higher risk than morphine, though long‐term data are limited.
Eward J. Melis, Johanna E. Vriezekolk, Frédérique H. C. Bollen, Dirk E. Schrander, Arnt F. A. Schellekens, Bart J. F. van den Bemt   +5 more
wiley   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source